SwastiChemEx: Endo's subsidiary Paladin launches Travelan in Canada

Monday 11 August 2014

Endo's subsidiary Paladin launches Travelan in Canada

Endo International plc's subsidiary Paladin Labs Inc. has launched Travelan, a unique over-the-counter product to help reduce the risk of travellers’ diarrhoea.

Travelan is clinically proven to provide protection against the main cause of travellers’ diarrhoea in 90 per cent of consumers who use it. Travelan is a convenient option for all those travelling to at-risk regions such as Central and South America, Mexico, Africa, the Middle East and Asia. It does not require a prescription, and is not associated with any significant side effects.

It is estimated that there are over 5 million trips made by Canadians to at-risk regions every year. One-in-three Canadian vacationers have experienced, or have travelled with someone who has experienced, travellers' diarrhoea. Sources of Enterotoxigenic Escherichia Coli (ETEC) bacteria, which cause the majority of cases of travellers' diarrhoea, can include poorly cooked meat, contaminated raw vegetables or unpasteurized dairy products. Given that no food group can be regarded as "safe"4, research demonstrates that three-quarters of Canadians have indicated that they would take a preventive for travellers’ diarrhoea.

No comments:

Post a Comment